首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   295899篇
  免费   27549篇
  国内免费   20860篇
耳鼻咽喉   2369篇
儿科学   3305篇
妇产科学   3606篇
基础医学   37347篇
口腔科学   4770篇
临床医学   40919篇
内科学   45631篇
皮肤病学   3135篇
神经病学   17347篇
特种医学   10794篇
外国民族医学   214篇
外科学   29158篇
综合类   45211篇
现状与发展   75篇
一般理论   29篇
预防医学   18454篇
眼科学   8810篇
药学   30623篇
  303篇
中国医学   16151篇
肿瘤学   26057篇
  2024年   983篇
  2023年   4602篇
  2022年   11896篇
  2021年   14993篇
  2020年   11242篇
  2019年   9999篇
  2018年   10644篇
  2017年   9223篇
  2016年   8798篇
  2015年   13006篇
  2014年   16031篇
  2013年   13960篇
  2012年   20805篇
  2011年   23641篇
  2010年   14323篇
  2009年   11139篇
  2008年   14903篇
  2007年   14968篇
  2006年   15138篇
  2005年   15293篇
  2004年   9498篇
  2003年   8850篇
  2002年   7555篇
  2001年   6796篇
  2000年   7514篇
  1999年   8141篇
  1998年   5073篇
  1997年   5043篇
  1996年   3932篇
  1995年   3717篇
  1994年   3101篇
  1993年   2131篇
  1992年   2727篇
  1991年   2338篇
  1990年   2038篇
  1989年   1764篇
  1988年   1582篇
  1987年   1368篇
  1986年   1120篇
  1985年   973篇
  1984年   603篇
  1983年   401篇
  1982年   234篇
  1981年   229篇
  1980年   170篇
  1979年   300篇
  1977年   124篇
  1976年   113篇
  1974年   130篇
  1972年   128篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
目的 探讨糖尿病前期的中医证型及证素分布特点。方法 检索中国知网、万方及维普三大数据库中收录的自建库以来有关糖尿病前期证型的临床研究文献,对中医证型进行规范整理,建立数据库,提取证素,运用数据挖掘技术中的关联分析、聚类分析探究证素分布规律。结果 共纳入10篇文献,总有效病例1620例,证型经规范处理后整理为18个,主要证型为脾虚痰湿证。共提取证素13个,主要病位证素为脾,主要病性证素为气虚、湿和痰,关联分析显示脾—湿支持度和置信度最高,聚类分析结果可得到3个聚类组。结论 糖尿病前期病位在脾,气虚、脾、痰、湿是常见证素,临床诊治糖尿病前期应注重从脾论治,需辨证施治。  相似文献   
82.
83.
PurposeWe previously demonstrated that the functional inactivation of DAL-1 and TOB1 promotes an aggressive phenotype in gastric cancer cells, but the links between both genes and the survival of patients with gastric cancer are unknown. Here, we investigated the correlations of the expression levels of DAL-1 and TOB1 with the progression of gastric cancer.MethodsA total of 270 patients who underwent resectable gastrectomy were included. The expression of DAL-1 and TOB1 was detected by immunohistochemistry.ResultsLow expression of DAL-1 in cancer tissue was significantly associated with tumor site (p < 0.05), histological grade (p < 0.01), depth of invasion (p < 0.05), lymph node metastasis status (p < 0.05), Lauren classification (p < 0.001), and clinical stage (p < 0.01). A lower level of TOB1 was observed in gastric cancer patients with diffuse type disease compared to patients with either intestinal or mixed type disease (p < 0.001). Additionally, Spearman’s correlation analysis revealed that decreased expression of DAL-1 was positively correlated with low TOB1 expression (r=0.304, p < 0.001). The survival analysis showed that low levels of DAL-1 and TOB1 were significantly associated with poor survival of gastric cancer patients (p <0.001 and p < 0.05, respectively).ConclusionThe downregulation of DAL-1 and TOB1 expression is associated with shorter survival of gastric cancer patients. Hence, DAL-1 and TOB1 may be considered potential novel markers for predicting the outcomes of patients with gastric cancer.  相似文献   
84.
1. To investigate Genkwa Flos hepatotoxicity, a cell metabolomics strategy combined with serum pharmacology was performed on human HL-7702 liver cells in this study.

2. Firstly, cell viability and biochemical indicators were determined and the cell morphology was observed to confirm the cell injury and develop a cell hepatotoxicity model. Then, with the help of cell metabolomics based on UPLC-MS, the Genkwa Flos group samples were completely separated from the blank group samples in the score plots and seven upregulated as well as two down-regulated putative biomarkers in the loading plot were identified and confirmed. Besides, two signal molecules and four enzymes involved in biosynthesis pathway of lysophosphatidylcholine and the sphingosine kinase/sphingosine-1-phosphate pathway were determined to investigate the relationship between Genkwa Flos hepatotoxicity and these two classic pathways. Finally, the metabolic pathways related to specific biomarkers and two classic metabolic pathways were analyzed to explain the possible mechanism of Genkwa Flos hepatotoxicity.

3. Based on the results, lipid peroxidation and oxidative stress, phospholipase A2/lysophosphatidylcholine pathway, the disturbance of sphingosine-1-phosphate metabolic profile centered on sphingosine kinase/sphingosine-1-phosphate pathway and fatty acid metabolism might be critical participators in the progression of liver injury induced by Genkwa Flos.  相似文献   

85.

Objective

To systematically review literature on uptake and timeliness of diphtheria-tetanus-pertussis, measles-mumps-rubella, and/or polio-containing vaccines in infants who were born preterm, with a low birth weight, and/or with chronic health conditions that were diagnosed within the first 6?months of life.

Methods

Using a standardized search strategy developed by a medical librarian, records were extracted from MEDLINE, Embase, Database of Abstracts of Reviews of Effects, and CINAHL up to May 8, 2018.

Results

Out of the 1997 records that were screened, we identified 21 studies that met inclusion criteria. Eleven studies assessed vaccine coverage and/or timeliness in preterm infants, 6 in low birth weight infants, and 7 in children with chronic health conditions. Estimates of coverage in these populations were highly variable, ranging from 40% to 100% across the vaccines and population groups.

Conclusions

There is a lack of studies reporting coverage and timeliness of routine immunizations in special populations of children.

Policy implications

Our review suggests a need for improved surveillance of immunization status in special populations of infants, as well as a need for standardization of reporting practices.  相似文献   
86.
87.
88.
89.
随着压力性损伤的研究重心逐渐向细胞水平转移,发现力学因素下细胞结构和功能改变在压力性损伤发展过程中起重要作用。综述力学因素下压力性损伤发生机制、影响因素、评估以及预防管理。旨在提高护理人员对压力性损伤更为深入地认知,从而推动压力性损伤研究多元化发展。  相似文献   
90.
随着腹腔镜肝切除技术的发展与推广,腹腔镜肝切除中的一些难点,如术中出血的控制、解剖性肝切除、巨大肝癌切除、腹腔镜下联合肝脏分割与门静脉支结扎的二步肝切除术(ALPPS)等方面均基本解决。术中超声与荧光染色技术也得到普及。本文就上述问题做一概述,并对腹腔镜肝切除未来发展提出思路,以进一步推动我国腹腔镜肝切除的技术进步。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号